Marabelle, A., Naing, A., Meric-Bernstam, F., Bao, X., Varga, A., Hong, D. S., . . . Ooi, C. E. First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE2-receptor E-type 4 (EP4), in patients with advanced cancers. BMJ Publishing Group.
Chicago Style (17th ed.) CitationMarabelle, Aurélien, et al. First-in-human Phase I Study of Immunomodulatory E7046, an Antagonist of PGE2-receptor E-type 4 (EP4), in Patients with Advanced Cancers. BMJ Publishing Group.
MLA (9th ed.) CitationMarabelle, Aurélien, et al. First-in-human Phase I Study of Immunomodulatory E7046, an Antagonist of PGE2-receptor E-type 4 (EP4), in Patients with Advanced Cancers. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.